Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: Results of a pilot study

David P. Steensma, Ruben A. Mesa, Chin Yang Li, Leigh Gray, Ayalew Tefferi

Research output: Contribution to journal › Article › peer-review

73 Scopus citations

Fingerprint

Dive into the research topics of 'Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: Results of a pilot study'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds